Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
about
High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis.Sclerostin, TNF-alpha and Interleukin-18 Correlate and are Together with Klotho Related to Other Growth Factors and Cytokines in Haemodialysis Patients.Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients.Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4.Serum Osteoprotegerin Levels Related With Cardiovascular Risk Factors in Chronic Kidney Disease.Receptor activator of nuclear factor κB ligand/osteoprotegerin axis and vascular calcifications in patients with chronic kidney disease.Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know.Osteoprotegerin Is the Strongest Predictor for Progression of Arterial Calcification in Peritoneal Dialysis Patients.Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis.Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease.Radial artery sclerostin expression in chronic kidney disease stage 5 predialysis patients: a cross-sectional observational study.Serum sclerostin: relation with mortality and impact of hemodiafiltration.Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?Bone markers and cardiovascular risk in type 2 diabetes patients.Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy.The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg ParadoxCirculating levels of sclerostin are associated with cardiovascular mortality.Osteoprotegerin and Cardiovascular Events in High-Risk Populations: Meta-Analysis of 19 Prospective Studies Involving 27 450 Participants
P2860
Q35985639-366CEE3A-70E2-4251-B079-92D0409EDA4CQ36538088-C737BF33-C564-4271-9708-C2618A123787Q36822357-37EB4D03-A89A-4C44-9D48-9BEB1609BDD3Q38584122-265C8B63-A275-4BD3-B864-F6A0F8789E30Q38920636-9D862B01-292B-4043-8DA5-C6F9B81491D1Q38955348-172983B6-768C-448B-A73E-7814B64B11ACQ39369106-99654EF9-E2FE-49BD-9E30-9DE7539101C6Q39552618-7B85EFAE-5F45-4538-BF8F-4F4ED90EE1F3Q39909061-A26A66E8-0C25-4FB0-9D56-F1C6D4D427F6Q40084826-7EF8EC5E-17E7-4BC4-A7A0-C582716C6590Q47630210-E8520293-0B52-43FB-B5F5-3780205F7B81Q47823030-01782E46-D49E-4D91-8DF1-AACDF220A479Q48025173-02596765-ED89-4F57-B6FF-142E90CE5E2BQ49719211-FDE89E3B-AC16-4821-A7D5-9CDD3179E3D9Q51028203-EACFE27D-C888-401B-8BC2-4D289DF39045Q53073924-AFAB3B06-1F42-4F30-8A5E-F7A30CAEE93AQ53342879-2B84B2C0-AE0E-4CCD-AD9D-F5252DFDE426Q53738261-9D01D84D-C75F-44C2-8DA6-CA737D61FF84Q55026099-540FB969-12B8-46BB-9A34-4348C75C377DQ55285084-902F1FA9-EEB5-49EE-882C-3FD1911CF61FQ55496723-47096639-DD94-4801-B89C-BECA263D6699Q58129712-7ECC074E-D63C-48F4-937A-9D3616EBA848
P2860
Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Osteoprotegerin and sclerostin ...... rs in vascular calcifications.
@en
type
label
Osteoprotegerin and sclerostin ...... rs in vascular calcifications.
@en
prefLabel
Osteoprotegerin and sclerostin ...... rs in vascular calcifications.
@en
P2093
P2860
P356
P1476
Osteoprotegerin and sclerostin ...... rs in vascular calcifications.
@en
P2093
Anne-Sophie Bargnoux
Bernard Canaud
Hélène Leray-Moragues
Hélène Vernhet
Jean-Paul Cristol
Kada Klouche
Leila Chenine
Marion Morena
Nils Kuster
P2860
P304
P356
10.1093/NDT/GFV081
P407
P577
2015-04-07T00:00:00Z